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We report a 10-year-old boy with syndromic cleft lip and palate (CLP) and neuro-psychomotor devel-
opmental delay. Oligoarray comparative genomic hybridization (aCGH) detected an approximately
300 kb interstitial microduplication at 5p15.33 encompassing 5 protein-coding genes, including TERT and
CLPTM1L, and two microRNA genes. Our ﬁndings suggest that the duplicated segment predisposes for
cleft lip with or without cleft palate (CL/P), or any of the other phenotypic features presented by the
patient. A gene coding a similar protein (CLPMT1) has been implicated in CLP etiology both through
linkage studies and by a translocation disrupting the gene, indicating the possible involvement of
CLPTM1L with CL/P. This is the ﬁrst report of a possible connection between CLPTM1L and CLP.
 2013 Elsevier Masson SAS. Open access under the Elsevier OA license.1. Clinical description
The patient was a 10-year-old boy, the ﬁrst child of healthy, non-
consanguineous parents. Nuchal translucency and CLP were
observed by fetal ultrasonography. He was born at term by
caesarean section due to an increased amniotic ﬂuid volume. Birth
parameters were: weight 3570 g (50th centile); length 51 cm (60th
centile). He had neuro-psychomotor developmental delay and was
not able to sit stably until 12 months. He started walking inde-
pendently at 26 months. Language started developing from 36
months onwards. At school age he was diagnosed with hyperac-
tivity and attention deﬁcit disorder. He exhibited downslanting
palpebral ﬁssures, low-set ears, prominent and wide nasal bridge,
and CLP, which were surgically corrected when he was 3 years old;
in addition he presented mild brachydactyly, atrio-ventricular
septal defect (closed spontaneously), cryptorchid testes and
micropenis.e Biologia Evolutiva, Instituto
o, SP, Brazil. Tel./fax: þ55 11
senberg).
der the Elsevier OA license.2. Methods
Routine G-banding chromosome analyzis from the patient were
performed on metaphase preparations from peripheral blood
lymphocytes using standard techniques at a resolution of 300e400
bands (low resolution) and showed an apparently normal (46,XY)
karyotype. MLPA analysis was carried out to test using the 964B,
070 and 036 kits for subtelomeric regions (MRC-Holland, Amster-
dam, Netherlands) and the results were normal.
DNA copy number was investigated by whole-genome array-
CGH (44K, Agilent Technologies, Santa Clara, CA) performed ac-
cording to the recommendations of the manufacturer. Data were
processed with Feature Extraction software and subsequently
analyzed with the Genomic Workbench software (both from Agi-
lent Technologies). Gains and losses of genomic sequences were
called using an aberration detection statistical algorithm ADM-2,
with a sensitivity threshold of 6.7. Detected copy number varia-
tions (CNVs) were compared to data from oligoarray studies
documented in the Database of Genomic Variants [DGV; http://
projects.tcag.ca/variation/]. All variants present in at least four
different studies in DGV were considered as normal population
variants (common), and subsequently disregarded. Chromosome
regions not previously reported as CNVs were singled out for
further investigations, which included conﬁrmatory studies by
real-time quantitative PCR (qPCR) using the TaqMan Copy
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tient’s and mother’s DNA were used in addition to a DNA sample
from a control individual. We used the TERT copy number assay as
target and compared the qPCR values with the ADAM12 and DOCK4
genes (normalization or reference genes). All samples were run in
triplicate and the data analyzed in Microsoft Ofﬁce Excel using an
Excel script to compute the comparative DDCt cycle threshold
(Applied Biosystems), which assumes that the calibrator DNA has
two copies of the control genes.Fig. 1. A. Ideogram of chromosome 5 showing the position of the duplication on the short ar
chromosome 5 of the patient. The red arrow points to the duplication site. C. High resolution
TERT gene copy number (three copies) was compared with those from ADAM12 and DOCK43. Genomic rearrangement
Array-CGH analysis revealed a microduplication at 5p15.33
(chr5:1,062,209-1,364,929; GRCh37/hg19) of approximately 300 kb
(Fig. 1C) encompassing 5 Refseq genes [NCBI Reference Sequence;
http://www.ncbi.nlm.nih.gov/], including TERT, CLPTM1L and three
SLC family members (Fig. 1A, B, C). The alteration description with
breakpoints according to ISCN (2013) is: arr 5p15.33(981,594x2,
1,062,209-1,364,929x3,1,429,655x2). The duplication wasm (bar). In detail, the RefSeq genes located in the duplicated area. B. aCGH proﬁle of the
view of the 300 kb duplicated segment at 5p15.33. D. Real-time quantitative PCR data.
(two copies), conﬁrming the duplication in the patient.
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showed that the patient carried three copies of the TERTgene, while
his mother and the control carried only two copies (Fig. 1D).
Whether the duplication was de novo or inherited could not be
deﬁnitely established since the father of the patient was unavai-
lable for investigation.
4. Discussion
Array-CGH detects genomic imbalances in 15e20% of patients
with multiple congenital abnormalities and/or intellectual
disability despite a prior normal karyotype, indicating the common
involvement of microdeletions or duplications in many congenital
diseases. The detection of CNVs has led to signiﬁcant advances in
identifying novel loci that contribute to many birth defects,
including syndromic CLP, particularly where the clinical description
does not closely ﬁt that of well-known syndromes.
CLP is genetically heterogenous and multifactorial, with
several loci contributing to the phenotype. We report a patient
exhibiting CLP, developmental delay, hyperactivity and minor
dysmorphisms in conjunction with a submicroscopic 5p15.33
duplication. Syndromic forms of CLP account for 5%e7% of all
cases and can result from interaction of multiple monogenic dis-
eases, chromosomal rearrangements, and/or the effect of random
environmental factors. This is the smallest duplication reported in
this chromosome region area and also the ﬁrst to associate
duplication of 5p15.33 with syndromic CLP. The duplicated region
includes 5 protein-coding genes: CLPTM1L; SLC12A7; SLC6A18;
SLC6A19; TERT, and two microRNA genes:MIR-4457 andMIR-4635.
Little is understood about the functions of the Solute Carrier
family genes (SLC12A7, SLC6A18, SLC6A19); however, several of
these genes have been associated previously with neurological
diseases, and it is plausible that duplication of these genes could
have contributed to the developmental delay of this patient.
Furthermore, it has already been observed that children with oral
clefts may present also increased inattention/hyperactivity risks
at older ages.
There is no overlap between the already known candidate
genes for syndromic CLP and the genes in the detected duplicated
region. The CLPTM1L (CLPTM1-like; OMIM 612585) gene e also
known as CRR9 (Cisplatin resistance-related protein 9) e encodes
a protein that shares a 35% identity with CLPTM1 (Cleft lip-and
palate-associated transmembrane protein-1), a protein encoded
by a gene located at 19q13.3 whose disruption by a balanced
translocation was reported in all members affected by CLP in a
three-generation family [1] (reviewed in OMIM 604783). The
same 19q13 region has been implicated also in non-syndromic
cleft lip with or without cleft palate (NSCLP) through linkage
and transmission disequilibrium studies [2], indicating a possible
association between CLPTM1 and NSCLP, although a 0.8 Mb dele-
tion at 19q13.3 not encompassing CLPTM1 has been reported,
suggesting the presence of more than one CLP gene in the region
[3]. Although CLPTM1 and CLPTM1L share a common domain
(InterPro database; http://www.ebi.ac.uk/interpro/), this is the
ﬁrst time that CLPTM1L has been associated with CLP. Due to the
similarity that the CLPTM1L protein domain shares with CLPTM1,
our ﬁndings raise a question on the role of the CLPTM1 gene
family in the cause of CLP. Yamamoto et al. [4] observed that
overexpression of the CLPTM1L gene in human ovarian tumor cell
lines induces in vitro apoptosis. In fact, CLPTM1L has been previ-
ously reported in the context of antidrug resistance, in particular
in cisplatin-induced apoptosis. Accordingly, a duplication of the
entire gene is likely to lead to increased gene expression, thus
triggering overexpression of apoptotic pathways, which may
contribute to phenotypical abnormalities, in particular CLP.In addition to CLP, our patient had a congenital heart defect.
TERT (Telomerase Reverse Transcriptase; OMIM 187270) gene al-
terations are related to several diseases, including susceptibility to
Coronary Artery Disease, and duplication of this gene could
possibly be related to the clinical manifestation of the patient. In
fact, two other duplications with phenotypic description in DECI-
PHER and overlapping TERT gene show heart alterations. The
combination of CLP, intellectual disability and heart defects is
also observed in the 22q11 Deletion Syndrome (DiGeorge/Veloc-
ardiofacial Syndromes).
Little is known about the two microRNA (miRNA) genes that
map within this duplication, but each of them has approximately
300 predicted targets [http://mirdb.org/miRDB/], including DRO-
SHA, a ribonuclease III involved in miRNA processing, whose
cofactor is DGCR8 (DiGeorge Syndrome Critical Region Gene 8); the
patient’s phenotype, including intellectual disability, may be
partially modulated by silencing of some of these predicted targets.
Partial or full trisomies of the short arm of chromosome 5 are
rare, although a number of cases have been described [review in
reference [5]; DECIPHER patient #4119]. The reported alterations
overlapping 5p13.55 are mostly deletions and generally much
larger than the alteration presented here. This is the ﬁrst descrip-
tion of a clinical phenotype involving CLP being attributed to
duplication of this small region; on the other hand, there is no
report of involvement of CLP among the patients carrying large
duplications encompassing the alteration in our patient, showing
that if CPLMT1L indeed plays a role in this phenotype, it possibly
shows a low penetrance which only manifests when a few genes
are involved in the duplication.
Although we have discussed the role of individual genes in each
phenotypic feature, the whole phenotype of the patient results
from the duplication of the full chromosome segment. Documen-
tation of additional cases is important to determine the role of the
duplicated genes, isolated or in combination, in the phenotypic
features of the patient. In particular, investigating copy number
alterations of the genes in this region in a cohort of CL/P patients
with intellectual disability and hyperactivity should help establish a
better phenotypeegenotype correlation.Conﬂicts of interest
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